FDA Registered vs. Cleared vs. Approved vs. Granted: Understanding Medical Device Regulatory Pathways

In the medical device industry, understanding the U.S. Food and Drug Administration’s (FDA) terminology is critical for compliance, market access, and patient safety.

Manufacturers frequently encounter the terms “FDA registered,” “FDA cleared,” “FDA approved,” and “FDA granted.” Though often used interchangeably, each has a distinct regulatory meaning, and misunderstanding them can lead to compliance gaps, delayed launches, or even enforcement actions.

This guide explains how these pathways differ, what each means for your device’s regulatory status, and how to strategically plan your U.S. submission.

FDA’s Role in Medical Device Regulation

The FDA regulates medical devices based on risk:

• Class I: Low-risk devices (e.g., bandages, surgical instruments) — most are exempt from premarket review but must comply with general controls
• Class II: Moderate-risk devices (e.g., diagnostic kits, infusion pumps) — typically require 510(k) clearance or, for novel devices, De Novo authorization
• Class III: High-risk or life-sustaining devices (e.g., implantables, pacemakers) — require Premarket Approval (PMA), the most rigorous pathway

Each class follows a distinct regulatory pathway, from registration and listing to 510(k) clearance or premarket approval (PMA), as defined in 21 CFR Part 807 and related guidance.

2026 Update: QMSR Now in Effect

A significant change affecting all device classes took effect on February 2, 2026. The FDA’s Quality System Regulation (QSR) has been replaced by the Quality Management System Regulation (QMSR), which incorporates ISO 13485:2016 by reference. Regardless of which submission pathway applies to your device, all manufacturers placing devices on the U.S. market must now operate under a QMSR-compliant quality management system. This affects establishment registration, premarket submissions, and post-market compliance activities across all three device classes.

FDA Registered: The Foundation for Market Entry

FDA registration is required for all domestic and foreign manufacturers selling devices in the U.S., regardless of device class. It is not an evaluation of device safety or effectiveness rather, it establishes a company’s presence within FDA’s records and enables oversight activities.

Purpose of FDA Registration

• Tracking Devices: Allows FDA to monitor all devices entering the market.
• Quality Control: Supports inspection readiness and adherence to Good Manufacturing Practices (GMP).
• Post-Market Surveillance: Enables FDA to audit, investigate, or recall products when necessary.

Tip: Registration is mandatory but does not authorize sales. Devices must meet labeling and quality requirements before commercialization.

FDA Cleared: The 510(k) Pathway

FDA clearance means the device is “substantially equivalent” to an existing legally marketed predicate device. Most Class II and some Class I devices use the 510(k) submission pathway, making it the most commonly used premarket pathway in the U.S.

Most Class II and some Class I devices use the 510(k) submission pathway.

Purpose of FDA Clearance

• Demonstrate Equivalence: Show the new device is as safe and effective as the predicate.
• Enable Market Entry: Clearance allows U.S. commercialization.
• Support Risk Classification: Confirms the device belongs in its designated risk class.

Step	Description	Typical Timeframe
Predicate Identification	Select comparable device	2–4 weeks
510(k) Submission	Submit data and comparison	~90 days
FDA Review & Clearance	Device cleared for sale	3–6 months

2026 Considerations

FDA staffing changes in 2025 and 2026 have stretched reviewer bandwidth, making complete, well-prepared submissions more important than ever. Manufacturers should also carefully evaluate predicate selection against current FDA guidance, as poorly chosen predicates remain a common source of rejection and delay. For modifications to existing cleared devices, the Special 510(k) program offers an accelerated 30-day review pathway.

Tip: Include all labeling, software details, and performance data. Missing predicate or incomplete information is a top reason for 510(k) clearance delays which is a risk amplified in 2026 by reduced reviewer availability.

FDA Approved: The Premarket Approval (PMA) Process

FDA approval is the highest level of regulatory scrutiny, applying to Class III devices that sustain life or pose significant risk. When a device is FDA approved, the agency has reviewed clinical evidence demonstrating it is safe and effective for its intended use.

PMA Process Overview

1. Conduct clinical trials under an Investigational Device Exemption (IDE).
2. Submit a comprehensive PMA application including data, manufacturing details, and labelingU aligned with QMSR requirements as of February 2026
3. Undergo FDA review, inspection, and advisory panel evaluation (if applicable)

Feature	510(k) Clearance	PMA Approval
Device Class	I–II	III
Predicate Device	Required	Not applicable
Clinical Data	Usually not required	Mandatory
Review Time	3–6 months	12-24+ months
Regulatory Burden	Moderate	High

Tip: For complex technologies, including AI-driven or implantable devices, early PMA planning and QMSR-aligned quality systems avoid costly re-submissions later.

FDA Granted: Designations for Innovation

“Granted” refers to special FDA designations designed to support novel technologies that address unmet clinical needs or don’t fit existing regulatory categories.

Tip: “Granted” designations don’t automatically mean market authorization, they enable a faster or customized review path toward clearance or approval.

Global Comparison: FDA vs. Other Market Pathways

Adding global context helps manufacturers plan multi-market strategies for device submissions.

U.S. FDA	EU MDR	Health Canada	Australia (TGA)
510(k) Cleared	CE Mark via Notified Body	Medical Device License	ARTG Inclusion
PMA Approved	CE Mark (Class III)	Class IV Device License	High-risk evaluation
De Novo Granted	Innovative Device Pathway	Special Access Program	Conformity Assessment

Tip: Align early with global standards like ISO 13485 and QMSR requirements to simplify multi-region submissions.  Both the FDA and EU MDR now anchor their quality system expectations to this standard.

Common Misconceptions & FAQs

Q: Is FDA registration the same as approval?
A: No. Registration identifies your company and devices with the FDA but does not involve any review of safety or efficacy.

Q: Can a device be both cleared and approved?
A: No. Devices follow one primary pathway based on their risk classification.

Q: What is the difference between clearance and approval?
A: Clearance is based on substantial equivalence to a predicate device (510(k)); approval requires direct clinical evidence of safety and effectiveness (PMA).

Q: What does “FDA granted” mean for my product?
A: It signifies eligibility for an expedited or customized review pathway, such as Breakthrough Device, De Novo, or PCCP, not final market authorization.

Q: Does the new QMSR affect my submission? 
A: Yes. As of February 2, 2026, all manufacturers must operate under a QMSR-compliant quality system regardless of device class or submission pathway. This affects registration, premarket submissions, and post-market compliance.

Expert Tips for Manufacturers

Tip #1: Classification drives your entire regulatory strategy- verify it early and revisit it if your intended use evolves.

Tip #2: Maintain robust, QMSR-aligned design documentation for seamless submissions and FDA inspections in 2026 and beyond.

Tip #3: For AI-enabled devices, file a Predetermined Change Control Plan (PCCP) upfront to manage future algorithm updates without triggering a new submission.

Tip #4: Stay proactive with post-market surveillance, compliance doesn’t end at approval, and regulators across all markets are increasing their post-market scrutiny.

Conclusion

Understanding the distinctions between FDA registration, clearance, approval, and granted designations helps medical device manufacturers navigate the U.S. regulatory landscape efficiently and confidently. With the QMSR now in effect and evolving expectations around AI, cybersecurity, and post-market evidence, staying current with FDA terminology and requirements is more important than ever.

Whether your device follows a 510(k) or PMA pathway, clarity around regulatory strategy ensures smoother market entry and better outcomes.

How RegDesk Can Help

RegDesk’s AI-powered Regulatory Information Management System (RIMS) simplifies global medical device compliance. With intelligence across 120+ markets, RegDesk helps you prepare and manage FDA and international submissions, track evolving standards and post-market requirements, and centralize global compliance in one platform.

Your regulatory pathway is always clear.